Clinical Trials Directory

Trials / Completed

CompletedNCT03211676

Comparison of Hemodialysis With Medium Cut-off Dialyzer (Theranova) and High Flux Dialyzer

Comparison of Hemodialysis With Medium Cut-off Dialyzer (Theranova) and High Flux Dialyzer on Removal of Small and Middle Size Molecules, Inflammatory Parameters and Oxidative Stress. An Open Cross Over Randomized Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
49 (actual)
Sponsor
Poitiers University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to evaluate the removal of midle molecules and inflammatory cytokines with the Theranova-500 ™ dialyzer (medium cut-off membrane, Baxter®) versus a high flux dialyzer Elisio-21H ™ (High-flux membrane, Nipro®) in chronic hemodialysis. Evaluation of nutritional parameters, inflamatory parameters and oxidative stress will also be carried out. Finally, the investigators will compare hepcidin levels and the erythropoietin resistance index between the two groups.

Conditions

Interventions

TypeNameDescription
DEVICETheranova-500 dialyzerhemodialysis with Theranova-500 dialyzer.
DEVICEElisio-21Hhemodialysis with Elisio-21H dialyzer

Timeline

Start date
2017-06-07
Primary completion
2018-03-14
Completion
2018-06-14
First posted
2017-07-07
Last updated
2020-04-13

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03211676. Inclusion in this directory is not an endorsement.

Comparison of Hemodialysis With Medium Cut-off Dialyzer (Theranova) and High Flux Dialyzer (NCT03211676) · Clinical Trials Directory